Veradigm | MDRX - Current Assets


Veradigm reported $679.65M in Current Assets for its fiscal quarter ending in December of 2022.





Current Assets Change Date
Alcidion AUD 28.52M 4.83M Dec/2025
Ambu A/S DKK 3.01B 33M Mar/2026
Amplifon EUR 442.25M 320.71M Jun/2026
Cardinal Health USD 38.75B 689M Jun/2026
Centene USD 46.68B 1.7B Jun/2026
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Cigna USD 46.99B 3.96B Jun/2026
Coloplast 10.3B 155M Dec/2025
Convatec Group USD 793.3M 70.6M Dec/2024
CVS Health USD 75.35B 529M Jun/2026
Diasorin EUR 759.63M 400.63M Jun/2025
Elevance Health USD 67.18B 152M Jun/2026
General Electric Aerospace USD 39.7B 664M Jun/2026
Gulf Medical Proj AED 450.52M 19.3M Mar/2026
Humana USD 38.08B 5.35B Mar/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
Laboratory Of America USD 3.81B 743.9M Jun/2026
Maximus USD 1.64B 132.51M Jun/2026
McKesson USD 62.84B 5.63B Jun/2026
Med Life RON 742.58M 47.12M Mar/2026
Molina Healthcare USD 12.93B 398M Jun/2026
Omnicell USD 735.39M 13.08M Jun/2026
Oriola-kd EUR 507.4M 149.5M Mar/2026
Owens Minor USD 271.45M 317.05M Jun/2026
Quest Diagnostics USD 2.84B 278M Jun/2026
Rede D'or Sao Luiz BRL 57.33B 2.54B Jun/2026
Siemens Healthineers EUR 14.96B 778M Jun/2026
Sonova Holding CHF 1.91B 466.3M Jun/2025
Supermax Corporation Bhd MYR 991.24M 93.68M Mar/2026
UnitedHealth USD 86.86B 4.27B Jun/2026
Veeva Systems USD 8.06B 65.63M Mar/2026
Veradigm USD 679.65M 131.12M Dec/2022
Xerox USD 3.7B 83M Jun/2026